
Targeting genomic mechanisms of resistance to immu...
Immunotherapies, such as CTLA-4 or PD-1 inhibitors, have revolutionized the treatment of metastatic melanoma patients. However, a key challenge to optimize the opportunity ...
Learn more about our upcoming Galas and Signature Events Learn More
Guest blog post by Ian Michael Crumm, Celebrity Esthetician, Podcast Host, Key Opinion Leader, Melanoma Advocate and 2025 #GetNaked Spokesperson: Some moments stick with yo...
Immunotherapies, such as CTLA-4 or PD-1 inhibitors, have revolutionized the treatment of metastatic melanoma patients. However, a key challenge to optimize the opportunity ...
Uveal melanoma is a type of melanoma that occurs in the eye as opposed to the most common presentations of melanoma, which occur on the skin. A diagnosis of uveal melanom...
Immune therapies termed “immune checkpoint inhibitors” remove key “brakes” on immune cells. These treatments lead to long-term responses and cures in some patients ...
Jun 26, 2025 ET
Jul 02, 2025 ET
Jul 15, 2025 ET